Skip to content

A retrospective observational study to evaluate the efficacy and safety of Jindan Fuyan granules in the treatment of lower limb lymphedema after pelvic malignant tumor surgery

A retrospective observational study to evaluate the efficacy and safety of Jindan Fuyan granules in the treatment of lower limb lymphedema after pelvic malignant tumor surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300068383
Enrollment
Unknown
Registered
2023-02-16
Start date
2023-02-17
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb lymphedema after pelvic malignancy

Interventions

Observation group:N/A

Sponsors

Zhejiang Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with pelvic malignant tumor after surgery; 2) In line with the diagnosis of lower limb lymphedema after pelvic malignant tumor surgery (including cases diagnosed as edema caused by diseases such as lymph reflux disorder and lymphocysts after pelvic malignant tumor surgery); 3) The prescription quantity of Jindan Fuyan granules should be at least 36 bags (15g per bag). Cases of edema caused by disorders of flow, lymphocysts, etc.); 3) The prescription quantity of Jindan Fuyan granules should be at least 36 bags (15g per bag).

Exclusion criteria

Exclusion criteria: 1) Lower limb edema caused by cardiogenic edema, renal edema and acute infection; 2) Patients who have undergone surgical treatment for lymphedema (transplantation or reconstruction to remove excess tissue of affected limb and restore lymphoid tissue function); 3) Patients without access to post-medication evaluation data.

Design outcomes

Primary

MeasureTime frame
Efficient;

Secondary

MeasureTime frame
Dosage and duration of treatment;Adverse events and occurrence rate;

Countries

China

Contacts

Public ContactLou Hanmei

Zhejiang Cancer Hospital

louhm@zjcc.org.cn13355783145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026